Literature DB >> 33707441

N6-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA.

Weinan Qiu1, Qingyang Zhang2,3, Rui Zhang4, Yangxu Lu1, Xin Wang1, Huabin Tian1, Ying Yang2,3, Zijuan Gu1, Yanan Gao1, Xin Yang2,3, Guanshen Cui2,3, Baofa Sun2,3, Yanan Peng1, Hongyu Deng1, Hua Peng1, Angang Yang4, Yun-Gui Yang5,6, Pengyuan Yang7,8.   

Abstract

Double-stranded RNA (dsRNA) is a virus-encoded signature capable of triggering intracellular Rig-like receptors (RLR) to activate antiviral signaling, but whether intercellular dsRNA structural reshaping mediated by the N6-methyladenosine (m6A) modification modulates this process remains largely unknown. Here, we show that, in response to infection by the RNA virus Vesicular Stomatitis Virus (VSV), the m6A methyltransferase METTL3 translocates into the cytoplasm to increase m6A modification on virus-derived transcripts and decrease viral dsRNA formation, thereby reducing virus-sensing efficacy by RLRs such as RIG-I and MDA5 and dampening antiviral immune signaling. Meanwhile, the genetic ablation of METTL3 in monocyte or hepatocyte causes enhanced type I IFN expression and accelerates VSV clearance. Our findings thus implicate METTL3-mediated m6A RNA modification on viral RNAs as a negative regulator for innate sensing pathways of dsRNA, and also hint METTL3 as a potential therapeutic target for the modulation of anti-viral immunity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707441      PMCID: PMC7952553          DOI: 10.1038/s41467-021-21904-y

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  56 in total

1.  Bridging innate and adaptive immunity.

Authors:  William E Paul
Journal:  Cell       Date:  2011-12-09       Impact factor: 41.582

2.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

3.  RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.

Authors:  Mengnuo Chen; Lai Wei; Cheuk-Ting Law; Felice Ho-Ching Tsang; Jialing Shen; Carol Lai-Hung Cheng; Long-Hin Tsang; Daniel Wai-Hung Ho; David Kung-Chun Chiu; Joyce Man-Fong Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

4.  High-resolution N(6) -methyladenosine (m(6) A) map using photo-crosslinking-assisted m(6) A sequencing.

Authors:  Kai Chen; Zhike Lu; Xiao Wang; Ye Fu; Guan-Zheng Luo; Nian Liu; Dali Han; Dan Dominissini; Qing Dai; Tao Pan; Chuan He
Journal:  Angew Chem Int Ed Engl       Date:  2014-12-09       Impact factor: 15.336

Review 5.  RNA epitranscriptomics: Regulation of infection of RNA and DNA viruses by N6 -methyladenosine (m6 A).

Authors:  Brandon Tan; Shou-Jiang Gao
Journal:  Rev Med Virol       Date:  2018-04-26       Impact factor: 6.989

Review 6.  Reading m6A in the Transcriptome: m6A-Binding Proteins.

Authors:  Deepak P Patil; Brian F Pickering; Samie R Jaffrey
Journal:  Trends Cell Biol       Date:  2017-11-02       Impact factor: 20.808

7.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

8.  METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.

Authors:  Hengyou Weng; Huilin Huang; Huizhe Wu; Xi Qin; Boxuan Simen Zhao; Lei Dong; Hailing Shi; Jennifer Skibbe; Chao Shen; Chao Hu; Yue Sheng; Yungui Wang; Mark Wunderlich; Bin Zhang; Louis C Dore; Rui Su; Xiaolan Deng; Kyle Ferchen; Chenying Li; Miao Sun; Zhike Lu; Xi Jiang; Guido Marcucci; James C Mulloy; Jianhua Yang; Zhijian Qian; Minjie Wei; Chuan He; Jianjun Chen
Journal:  Cell Stem Cell       Date:  2017-12-28       Impact factor: 25.269

9.  RNA m6A methylation regulates the ultraviolet-induced DNA damage response.

Authors:  Yang Xiang; Benoit Laurent; Chih-Hung Hsu; Sigrid Nachtergaele; Zhike Lu; Wanqiang Sheng; Chuanyun Xu; Hao Chen; Jian Ouyang; Siqing Wang; Dominic Ling; Pang-Hung Hsu; Lee Zou; Ashwini Jambhekar; Chuan He; Yang Shi
Journal:  Nature       Date:  2017-03-15       Impact factor: 49.962

Review 10.  N6-Methyladenosine and Viral Infection.

Authors:  Wei Dang; Yan Xie; Pengfei Cao; Shuyu Xin; Jia Wang; Shen Li; Yanling Li; Jianhong Lu
Journal:  Front Microbiol       Date:  2019-03-05       Impact factor: 5.640

View more
  23 in total

Review 1.  Function of m6A and its regulation of domesticated animals' complex traits.

Authors:  Siyuan Mi; Yuanjun Shi; Gerile Dari; Ying Yu
Journal:  J Anim Sci       Date:  2022-03-01       Impact factor: 3.159

Review 2.  How RNA modifications regulate the antiviral response.

Authors:  Matthew G Thompson; Matthew T Sacco; Stacy M Horner
Journal:  Immunol Rev       Date:  2021-08-17       Impact factor: 12.988

Review 3.  Impact of N6-methyladenosine (m6A) modification on immunity.

Authors:  Raghda A Elsabbagh; Mona Rady; Carsten Watzl; Khaled Abou-Aisha; Mohamed Z Gad
Journal:  Cell Commun Signal       Date:  2022-09-09       Impact factor: 7.525

Review 4.  One genome, many cell states: epigenetic control of innate immunity.

Authors:  Isabella Fraschilla; Hajera Amatullah; Kate L Jeffrey
Journal:  Curr Opin Immunol       Date:  2022-04-08       Impact factor: 7.268

Review 5.  Biological roles of adenine methylation in RNA.

Authors:  Konstantinos Boulias; Eric Lieberman Greer
Journal:  Nat Rev Genet       Date:  2022-10-19       Impact factor: 59.581

6.  Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.

Authors:  Hyeongjwa Choi; Juntae Kwon; Min Soon Cho; Yifan Sun; Xiaofeng Zheng; Jing Wang; Kerrie B Bouker; John L Casey; Michael B Atkins; Jeffrey Toretsky; Cecil Han
Journal:  Cancer Res       Date:  2021-05-03       Impact factor: 12.701

Review 7.  Synthetic modified messenger RNA for therapeutic applications.

Authors:  Minsong Gao; Qingyi Zhang; Xin-Hua Feng; Jianzhao Liu
Journal:  Acta Biomater       Date:  2021-06-13       Impact factor: 8.947

Review 8.  From A to m6A: The Emerging Viral Epitranscriptome.

Authors:  Belinda Baquero-Perez; Daryl Geers; Juana Díez
Journal:  Viruses       Date:  2021-06-01       Impact factor: 5.048

9.  Targeting the m6A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.

Authors:  Hannah M Burgess; Daniel P Depledge; Letitia Thompson; Kalanghad Puthankalam Srinivas; Rebecca C Grande; Elizabeth I Vink; Jonathan S Abebe; Wesley P Blackaby; Alan Hendrick; Mark R Albertella; Tony Kouzarides; Kenneth A Stapleford; Angus C Wilson; Ian Mohr
Journal:  Genes Dev       Date:  2021-06-24       Impact factor: 11.361

10.  N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses.

Authors:  Hideki Terajima; Mijia Lu; Linda Zhang; Qi Cui; Yanhong Shi; Jianrong Li; Chuan He
Journal:  PLoS Biol       Date:  2021-07-29       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.